Medtronic plc (NYSE:MDT) registered a 1.23% increase, still its new closing price is 8.07% up from the company’s 1 year high of 88.74.It posted -0.05% losses in previous 5 sessions and is now the subject of 9 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 8 buy or better ratings. The 26 stock analysts following this company have an average price target at $84.54, with individual PT in the $77.00-$96.00 range. The shares moved at $74.95, implying that brokerage firms see shares gaining about 3.04% in twelve months time.
Medtronic plc (MDT) SEC Form 4 News
The stock is getting much attention these days as insiders are adding shares while they posted a 5.22% rise year to date. A Director at Medtronic plc (MDT) acquired shares in a transaction closed on Tuesday December 13, 2016. POZEN ROBERT C bought 13,660 shares in the company at $73.21 each and collected $1,000,000 in proceeds. POZEN ROBERT C now owns 67,223 shares in the company after this transaction. A Director in the company, Lenehan James T, disclosed a transaction on Wednesday November 23, 2016 that ended up paying $146,001 from the purchase of 2,000 shares at $73.27 per share.
Medtronic plc (NYSE:MDT) Upcoming Results on Tap
Medtronic plc will next provide financial results for the July 2017 quarter. Stock analysts expect it to report per-share earnings of $1.14 in that period. Sales during the quarter are predicted to arrive at $7.47 billion.
Earnings surprise history: Last quarter, the company posted approximately $7.35 billion in revenue and EPS of $1.12. The mean forecast was for $7.46 billion and $1.11 a share, respectively. One quarter earlier, revenue for the stock was at $7.17 billion, with earnings at $1.03/share.
Medtronic plc (MDT) Brokerage Update
Medtronic plc (MDT) is in BofA/Merrill’s research list so their analyst rating change is noteworthy. These shares were downgraded to Neutral from Buy by BofA/Merrill, according to news reported on Tuesday January 03, 2017.Another important research note was issued by JP Morgan on Tuesday January 03, 2017.The firm downgraded MDT to Neutral from Overweight. Over the last six months and over the last three months, the shares of Medtronic plc (MDT), have changed -13.75% and -7.05%, respectively.